The US FDA is hoping that the National Academies of Sciences, Engineering, and Medicine (NASEM) can help develop opioid prescribing guidelines that are highly specific, although experts cautioned there are some areas where guidelines may need to be more generalizable.
Speaking at a Feb. 4 meeting hosted by NASEM's Committee on Evidence-based Clinical Practice Guidelines for Prescribing Opioids for Acute...




